Document Page: First | Prev | Next | All | Image | This Release | Search
File: 120396_sep96_decls1_0032.txt
Subject: MPOD 3821 CHRONOLOGY
Unit: OTSG
Parent Organization: HSC
Box ID: BX003202
Folder Title: CHRONOLOGY
Document Number: 1
Folder SEQ #: 29
UNCLASSIFIED
received the botulinum pentavalent toxoid while servi@
Arabia. Responded to by Army. Conclusion was that the
considered safe and effective. Thre is no data to suggeb
the toxoid causes any problems in pregnant women or in mall
child-bearing age.
140. 27 Nov 91 - Army sent draft DOD Biological Defense Plan t(-
Joint Staff (J-5) for comment. This report was due to DEPSECDEF
not later than 30 Nov 91. The plan addressed the near-term, high
priority biological needs of the armed forces, including defense
against AX and BT threat agents. Additionally, the plan provided
enhancements to achieve an adequate biological defense for the
1995 force against the most probable biological warfare threats.
141. 10 Dec 91 - Joint Staff comments to 27 Nov plan (staffed
with Service planners) included comments on the threat section
(too long); made clear that review by CINC action officers was not
an established CINC position; emphasized that vaccine for BT
remains deficient; recommended costs be carefully checked for all
alternatives; requested more full explanation be given to what was
in the core program (chemical and biological). The plan was only
partially reflective of the discussion emanating from the 30 Oct
TANK briefing. OSD comments were not as favorable and requested
plan be reworked with OSD comments more fully integrated; plan
needed clarification regarding specific milestones, funding
requirements, recommendations backed by analysis. The set of
options needed better organization so as to allow selection of
best course of action. Two components of plan (peacetime
vaccination and adequate vaccine production) should be immediately
mplished.
142. 7 Feb 92 - Final version of plan forwarded by CSA to CJCS
for guidance before submission to SECARMY who will forward it to
DEPSECDEF. Plan programmed (core) money for chemical/biological
defense is $1.318B. identified comprehensive way to satisfy
DEPSECDEF taskings by offering incremental packages of selected
capabilities. Total unfinanced costs recommended are $962M. Key
issues: Army has identified several alternatives having
unprogrammed costs but has not restructured/reprogrammed core
program or identified other sources to offset additional costs;
there is no vaccination policy; there is a lack of consensus on
the threat. Navy and Air Force do not see the same threat to
their forces as do ground forces. Conclusions: Joint Staff
should continue to support biological defense as a priority
requirement; support construction of a scaled-back vaccine
facility; support innoculation of special operations forces and
3 2
UNCLASSIFIED
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 33 f:/Week-36/BX003202/CHRONOLOGY/mpod 3821 chronology:1108961508372
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003202
Unit = OTSG
Parent Organization = HSC
Folder Title = CHRONOLOGY
Folder Seq # = 29
Subject = MPOD 3821 CHRONOLOGY
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 08-NOV-1996